Comparison of Hepatitis B Virus Infection in HIV-Infected and HIV-Uninfected Participants Enrolled in a Multinational Clinical Trial: HPTN 052
暂无分享,去创建一个
C. Thio | M. Hosseinipour | B. Grinsztejn | S. Badal‐Faesen | M. Nyirenda | N. Kumarasamy | Y. Chen | S. Eshleman | J. Pilotto | E. Piwowar-Manning | S. Ou | J. Makhema | A. Valsamakis | E. Wilson | R. Panchia | M. Mccauley | T. Gamble | M. Forman | C. Ruangyuttikarn | A. Greer | V. Akelo | Natthapol Kosashunhanan | M. Cohen | Marineide Gonçalves de Melo | S. Badal-Faesen | M. Cohen | M. McCauley | Victor Akelo
[1] E. Valore,et al. Mice lacking liver-specific β-catenin develop steatohepatitis and fibrosis after iron overload. , 2017, Journal of hepatology.
[2] Thomas Berg,et al. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. , 2017, Journal of hepatology.
[3] B. Chi,et al. Liver fibrosis in treatment-naïve HIV-infected and HIV/HBV co-infected patients: Zambia and Switzerland compared. , 2016, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[4] B. Chi,et al. Association between hepatitis B co‐infection and elevated liver stiffness among HIV‐infected adults in Lusaka, Zambia , 2016, Tropical medicine & international health : TM & IH.
[5] J. Gallant,et al. Antiretroviral Therapy for the Prevention of HIV-1 Transmission. , 2016, The New England journal of medicine.
[6] J. Phair,et al. Brief Report: Highly Active Antiretroviral Therapy Mitigates Liver Disease in HIV Infection , 2016, Journal of acquired immune deficiency syndromes.
[7] N. Budambula,et al. Erratum to: Hepatitis B virus sero-profiles and genotypes in HIV-1 infected and uninfected injection and Non-injection drug users from coastal Kenya , 2015, BMC Infectious Diseases.
[8] R. Weber,et al. HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected persons , 2015, BMC Gastroenterology.
[9] R. Kahn,et al. Prevalence of HIV and Hepatitis B Virus Co-Infection in Sub-Saharan Africa and the Potential Impact and Program Feasibility of Hepatitis B Surface Antigen Screening in Resource-Limited Settings , 2015, Journal of acquired immune deficiency syndromes.
[10] M. Chayakulkeeree,et al. Clinical characteristics of hepatitis B and C virus infections in HIV-infected patients. , 2015, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.
[11] W. Preiser,et al. The HIV/HBV co-infected patient: Time for proactive management. , 2015, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[12] P. Klenerman,et al. Epidemiology and impact of HIV coinfection with hepatitis B and hepatitis C viruses in Sub-Saharan Africa. , 2014, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[13] C. Spada,et al. The prevalence of hepatitis B virus infection markers and socio-demographic risk factors in HIV-infected patients in Southern Brazil. , 2014, Revista da Sociedade Brasileira de Medicina Tropical.
[14] Ajit Kumar,et al. Hepatitis B and/or C co-infection in HIV infected patients: A study in a tertiary care centre from south India , 2013, The Indian journal of medical research.
[15] B. Berkhout,et al. High prevalence of hepatitis B virus dual infection with genotypes A and G in HIV-1 infected men in Amsterdam, the Netherlands, during 2000-2011 , 2013, BMC Infectious Diseases.
[16] M. Tsai,et al. Hepatitis B virus (HBV) coinfection accelerates immunologic progression in patients with primary HIV infection in an area of hyperendemicity for HBV infection. , 2013, The Journal of infectious diseases.
[17] S. Chakrabarti,et al. Characterization of Treatment-Naive HIV/HBV Co-Infected Patients Attending ART Clinic of a Tertiary Healthcare Centre in Eastern India , 2013, PloS one.
[18] P. Peters,et al. An Evaluation of Hepatitis B Virus Diagnostic Methods and Responses to Antiretroviral Therapy among HIV-Infected Women in Thailand , 2013, Journal of the International Association of Providers of AIDS Care.
[19] S. Nanta,et al. Prevalence, risk factors, and impact of isolated antibody to hepatitis B core antigen and occult hepatitis B virus infection in HIV-1-infected pregnant women. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[20] C. Thio,et al. Predictors of the isolated hepatitis B core antibody pattern in HIV-infected and -uninfected men in the multicenter AIDS cohort study. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[21] S. Kulkarni,et al. Characterization of HIV–HBV coinfection in a multinational HIV-infected cohort , 2013, AIDS.
[22] S. Eholie,et al. Prevalence and virological profiles of hepatitis B infection in human immunodeficiency virus patients. , 2012, World journal of hepatology.
[23] Michael Rayment,et al. Prevention of HIV-1 infection with early antiretroviral therapy , 2012, Journal of Family Planning and Reproductive Health Care.
[24] C. Thio,et al. HIV monoinfection is associated with increased aspartate aminotransferase-to-platelet ratio index, a surrogate marker for hepatic fibrosis. , 2012, The Journal of infectious diseases.
[25] Helen M. Chun,et al. Hepatitis B virus coinfection negatively impacts HIV outcomes in HIV seroconverters. , 2012, The Journal of infectious diseases.
[26] William M. Lee,et al. Hepatitis B virus genotype G: Prevalence and impact in patients co‐infected with human immunodeficiency virus , 2011, Journal of medical virology.
[27] J. Kostman,et al. Prevalence and risk factors for significant liver fibrosis among HIV-monoinfected patients , 2010, BMC infectious diseases.
[28] Tai‐Jui Chen,et al. Risk Factors of Isolated Antibody Against Core Antigen of Hepatitis B Virus: Association With HIV Infection and Age but not Hepatitis C Virus Infection , 2010, Journal of acquired immune deficiency syndromes.
[29] Michael Y. Lin,et al. Long-term serologic follow-up of isolated hepatitis B core antibody in HIV-infected and HIV-uninfected women. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[30] C. Thio,et al. Clinical implications of HIV and hepatitis B co-infection in Asia and Africa. , 2007, The Lancet. Infectious diseases.
[31] M. Young,et al. Isolated hepatitis B core antibody is associated with HIV and ongoing but not resolved hepatitis C virus infection in a cohort of US women. , 2007, The Journal of infectious diseases.
[32] B. McMahon,et al. Chronic hepatitis B. , 2002, The New England journal of medicine.
[33] P. Alm. Coinfection of hepatitis B and hepatitis C virus in HIV-infected patients in south India , 2007 .
[34] A. Lok,et al. Natural history of chronic hepatitis B virus infection: What we knew in 1981 and what we know in 2005 , 2006, Hepatology.
[35] A. Vibhagool,et al. Prevalence of hepatitis B virus and hepatitis C virus co-infection with human immunodeficiency virus in Thai patients: a tertiary-care-based study. , 2004, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.
[36] S. Schaefer,et al. Hepatitis B virus genotypes: comparison of genotyping methods , 2004, Reviews in medical virology.
[37] J. Phair,et al. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS) , 2002, The Lancet.
[38] M. L. Rodriguez-Mendez,et al. Prevalence, patterns, and course of past hepatitis B virus infection in intravenous drug users with HIV-1 infection , 2000, American Journal of Gastroenterology.
[39] M. Loriot,et al. Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men , 1999, Hepatology.
[40] Bernice W. Polemis. Nonparametric Statistics for the Behavioral Sciences , 1959 .